Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Amortization of Deferred Charges (2016 - 2017)

Historic Amortization of Deferred Charges for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to $9794.0.

  • Bone Biologics' Amortization of Deferred Charges fell 2.04% to $9794.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $39177.0, marking a year-over-year decrease of 2876.39%. This contributed to the annual value of $21283.0 for FY2018, which is 4567.48% down from last year.
  • According to the latest figures from Q4 2017, Bone Biologics' Amortization of Deferred Charges is $9794.0, which was down 2.04% from $9795.0 recorded in Q3 2017.
  • Over the past 5 years, Bone Biologics' Amortization of Deferred Charges peaked at $25613.0 during Q1 2016, and registered a low of $9793.0 during Q3 2016.